Document is current
Any future updates will be listed below
-
Authors
Joshkon, Ahmad
Tabouret, Emeline
Traboulsi, Wael
Bachelier, Richard
Simoncini, Stéphanie
Roffino, Sandrine
Jiguet-Jiglaire, Carine
Badran, Bassam
Guillet, Benjamin
Foucault-Bertaud, Alexandrine
Leroyer, Aurelie S.
Dignat-George, Françoise
Chinot, Olivier
Fayyad-Kazan, Hussein
Bardin, Nathalie
Blot-Chabaud, Marcel http://orcid.org/0000-0003-0152-3893
-
Funding
Funding for this research was provided by:
MSDAVENIR
Inserm Transfert
Aix-Marseille Université
- License Information
-
More Information
Article History
Received: 23 June 2022
Accepted: 28 September 2022
First Online: 23 October 2022
Declarations
:
: Plasma samples from patients with GBM were obtained from Assistance Publique-Hôpitaux de Marseille Tumor Bank, authorization number AC2018-31053; CRB BB-0033–00097. Informed consent of patients was obtained. All animal experiments were conformed to the directive 2010/63/EU of the European Parliament and approved by the Institution’s Animal care and Use Committee (Aix-Marseille University). Additional Materials and Methods are in additional data.
: The authors declare no competing interests.
